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Abstract 
Conclusion: Unilateral congenital deafness with a volume reduction in cochlear nucleus 
(CN) induced changes in the Calcium-binding proteins (CaBPs) in the contralateral 
superior olivary complex (SOC) in rat.  With the loss of neurons and a volume 
reduction in the CN, a decrease in the input to the contralateral SOC may occur, which 
results in the downregulation of CaBPs in these nuclei.  This study may provide some 
implications regarding the neurochemistry in the auditory brainstem of deaf children. 
Objectives: Hearing loss produced by cochlear damage during early development can 
result in persistent changes in the organization of the central auditory system in adults.  
The purpose of the present study was to investigate the neurochemical changes 
produced in the auditory brainstem of rats with unilateral cochlear ablation conducted 
prior to the onset of hearing. 
Methods: Following unilateral cochlear ablation during early development, we 
examined the changes in the distribution of two CaBPs, calbindin-D28k (CB) and 
parvalbumin (PV), in the SOC. 
Results: Upon reaching adulthood, a marked decrease in CB and PV-immunoreactive 
neurons was observed in the contralateral SOC, particularly in the medial nucleus of the 
trapezoid body (MNTB), although no neuronal cell death was observed.  A volume 
reduction in the ipsilateral CN was also observed. 
 
Key Words: Unilateral cochlear ablation, development, superior olivary complex 
(SOC), cochlear nucleus (CN), calcium-binding protein 
 
Abbreviations 
SOC, superior olivary complex; MNTB, medial nucleus of the trapezoid body; LSO, 
lateral superior olive; MSO, medial superior olive; SPN, superior periolivary nucleus; 
CN, cochlear nucleus; AVCN, anterior ventral cochlear nucleus; PVCN, posterior 
ventral cochlear nucleus; DCN, dorsal cochlear nucleus; CaBPs, calcium-binding 
proteins; CB, calbindin-D28k; PV, parvalbumin; ABR, auditory brainstem response 
Inroduction 
Brain plasticity is a complex property that undergoes massive developmental 
changes after birth.  In general, input deprivation in the nervous system causes 
functional and structural changes through expression of neural plasticity.  Hearing loss 
produced by cochlear damage during early development can result in dynamic changes 
in the organization of the central auditory structures in adults.  These changes include 
morphological and neurochemical changes in neurons, re-routing of neural connections, 
and abnormal physiological responses of the neurons in the auditory hindbrain, 
midbrain and forebrain.  For example, congenital deafness results in physiological and 
anatomical transneural changes in auditory brainstem nuclei [1].  In gerbils, following 
early unilateral cochlear lesions, neurons in the ventral cochlear nucleus (VCN) on the 
side of the lesion establish abnormal connections with the superior olivary complex 
(SOC), including inappropriate targets within the ipsilateral medial nucleus of the 
trapezoid body (MNTB), bilateral medial superior olive (MSO) and the contralateral 
lateral superior olive (LSO) [1, 2].  Other studies of animal models of deafness have 
shown abnormal synaptic terminals of the auditory nerve [3].  Despite the many 
morphological studies that have investigated the changes in the central auditory system 
caused by cochlear ablation before the onset of hearing, the neurochemical plasticity 
still remains unknown.  In addition, there have been no reported studies that have 
examined the changes in the neurotransmitter release in animals with cochlear damage. 
 Calbindin D-28k (CB) and parvalbumin (PV) are widely expressed in the 
brainstem auditory nuclei [4, 5].  CB and PV are calcium-binding proteins (CaBPs) 
that exist in distinct subpopulations of neurons within the central nervous system [6].  
The pattern of CB immunostaining in the SOC and CN has been well characterized in 
rat, guinea pig, and cat [4, 7].  All of these studies have reported that CB 
immunoreactivity is present in every principal nucleus within the SOC.  In addition, all 
nuclei of the SOC contained abundant PV-immunoreactive elements [8].  The pattern 
of PV immunostaining in the SOC also has been well characterized in rat and guinea pig 
[8].  CaBPs are involved in the release of neurotransmitters, the functioning of ion 
channels in the neuronal membranes, and the regulation of enzyme activities at pre- and 
postsynaptic sites and during synaptic short-time plasticity [9].  They are sequentially 
expressed during the auditory brainstem development.  Upon maturation, CB is 
drastically reduced or entirely lost in many auditory nuclei, while PV appears relatively 
late in the somata and then rapidly increases to adult levels.  During neuronal 
development, it is believed that CaBPs could be involved in buffering the intracellular 
free Ca2+ concentration, which may be necessary for modification of synaptic 
efficiency [4, 8].   
In the auditory pathway, unilateral deaf models are frequently used to identify 
the effects of monaural hearing loss, as this allows for straightforward comparisons to 
be made between the uptakes in both the normal and deprived sides within the same 
animal.  However, in the rat auditory system ontogeny, there have been few systemic 
studies that examined the neurons containing CaBPs [4, 8].  In the present study, we 
investigated the changes in the CaBP expressions within the auditory brainstem in an 
animal model with congenital deafness.  Unilateral cochlear ablations before the onset 
of hearing have been used as models of congenital deafness.  This study may provide 
some implications regarding the neurochemistry in the auditory brainstem of deaf 
children. 
 
Materials and methods 
Animals and Surgical Procedures 
 A total of 10 adult male and female Sprague–Dawley rats were used.  The 
Animal Research Committee of Kanazawa University Graduate School of Medical 
Science approved the care and use of the animals in the present study.  Postnatal day 0 
(P0) to P1 newborn rats in the experimental group (n=7) were anesthetized by 
hypothermia and a skin incision was made inferior to the right pinna.  The lateral 
semicircular canal and middle ear soft tissue were exposed by blunt dissection, taking 
care to avoid injury to the facial motor nerve.  After removing the stapes, a syringe 
needle was inserted through the oval window into the cochlea and the cochlea contents 
were aspirated.  The skin incision was closed with glue.  The newborn rats were 
allowed to recover under a heating lamp and returned to their mother after recovery.  In 
addition to these 7 experimental animals, three normal, 4-month-old rats served as 
unmanipulated controls.  
Hearing Loss Assessment 
Auditory function was assessed by recording auditory brainstem response 
(ABR).  The measurements of ABR thresholds were performed at frequencies of 4, 8 
and 16 kHz after a post-surgical survival time of 4 months.  Animals were anesthetized 
with pentobarbital sodium (50 mg/kg ip) and kept warm with a heating pad.  
Thresholds at each frequency were verified at least twice.  An 80-dB shift from the 
normal control threshold averaged across the three frequencies was considered to 
represent deafness. 
Tissue Processing 
After ABR assessment, the deaf animals were immediately given an injection 
of pentobarbital sodium (120 mg/kg ip) and perfused transcardially with 
phosphate-buffered saline followed by 4% paraformaldehyde.  The brains were 
removed and post-fixed in the same fixative overnight and stored in a 30% sucrose 
buffer for several days, and cut serially at 40 μm in the frontal plane on a freezing 
microtome (Leica SM 2000R).  Typically each brain was cut into three alternating 
series of section, one of which was used for counterstaining with cresyl violet and the 
other two were analyzed by immunocytochemistry.  
CB and PV Immunocytochemistry 
Free-floating sections were incubated in 0.03% H2O2 for 10 min to block 
unspecific peroxidase activity.  Sections were then washed with phosphate-buffered 
saline (0.1 M; PBS) with 0.2% Triton X-100 (PBST) and incubated with a primary 
antibody overnight at room temperature.  The primary antibody was either a mouse 
monoclonal antibody against CB (Sigma, St. Louis, MO, USA; clone CB-955; dilution 
of 1:12000) or a mouse monoclonal antibody against PV (Sigma; clone PA-235; dilution 
of 1:30000).  The primary antibodies were detected using the EnVision+ System 
(DakoCytomation California, Carpinteria, CA, USA).  Sections were incubated with 
the 3,3'-diaminobenzidine (DAB) substrate-chromagen solution (EnVision+ System) for 
5 min.  Finally, sections were washed in PBS and then mounted on gelatin-coated 
slides.  
Analysis of MNTB 
 Sections were examined by bright-field microscopy using either a × 40 or a × 
60 lens (Nikon Eclipse E1000 microscope; Nikon, Auckland, New Zealand), with 
images captured using a Nikon digital camera DXM1200C (Nikon).  Labeled neurons 
in the MNTB were counted on the cresyl violet and immunocytochemical sections.  
For a neuron to be counted in the cresyl violet section, a well-defined cytoplasm and 
nuclear outline with a clearly visible nucleolus had to be present.  Neuron counts were 
obtained from the MNTB on both sides of the brainstem.  Immunocytochemically 
positive cells were characterized by the orange/brown DAB labeling, whereas negative 
cells exhibited no labeling.  Cells were considered to be immunopositive when they 
displayed stained brown somata.  
Optical Density Measurement 
 The lesion-induced effects on CB and PV expression were assessed by 
determination of the optical density in the superior paraolivary nucleus (SPN) and LSO 
using Image J software (NIH, Bethesda, MD, USA).  For each animal, a mean 
operated and non-operated optical density ratio was determined. 
Measurements of Cochlear Nucleus Volume 
 Using Image J software (NIH), the perimeters of the VCN and the dorsal 
cochlear nucleus (DCN) were traced (10 × objective) from the cresyl violet sections.  
The total volume of each nucleus was then estimated from the total areas of the sections. 
Image Processing 
 To prepare the figures shown here, the size and brightness of each image was 
adjusted using Adobe Photoshop CS (Version 8.0.1).  These adjustments in no way 
altered the immunostaining pattern of each antibody. 
Statistical Analysis 
 All data are expressed as the mean ± SD and were analyzed statistically by 
using a Student’s t-test.  Statistical significance was determined at the p < 0.05 level.  
The evaluation and data analyses were made by experimentally blind observers. 
 
Results 
 No ABR waves were elicited at any frequency, even at 105 dB SPL, in 
cochlear ablated side, indicative of deafness.  Although the area of the contralateral 
MNTB was about 60% to 80% of the size of the ipsilateral MNTB (Fig. 1A), neonatal 
cochlear ablation did not result in any loss of neurons in the MNTB (Figs. 1A and B, 
Table 1), as determined by cresyl violet staining.  The total number of neurons in the 
MNTB was 1133.4 ± 208.5 on non-operated (left) and 1199.1 ± 114.9 on operated 
(right) side.  In the controls, somata were positively stained for CB and PV in the 
MNTB, where virtually every CB or PV immunoreactive neuron was heavily labeled.  
In contrast to counts seen for the cresyl violet cells, there was a significant difference 
between the sides for the number of CB positive neurons in the MNTB, with 162.4 ± 
70.4 on non-operated (left) and 327.9 ± 84.4 on operated (right) side. (Figs. 1C and D, 
Table 1)  The number of PV positive neurons in the MNTB also had significantly 
difference between the sides, with 151 ± 96.3 on non-operated (left) and 254.1 ± 114.2 
on operated (right) side.  With early cochlear ablation, there was a substantial 
reduction in the number of CB and PV immunopositive cells in the MNTB on the side 
that was contralateral to the ablation (Figs. 1E and F, Table 1).   
----- Figure 1 and Table 1 Here----- 
 In contrast to the MNTB, in normal animals there were very few CB positive 
somata seen in the LSO and those were weakly stained.  In the SPN, almost all 
immunoreactivity was restricted to the neuropil.  There were no differences in the 
expression and staining of these proteins between the left and right sides in the control 
animals.  As determined by optical density, there was a decrease in neuropil density 
observed in the contralateral LSO and SPN following unilateral cochlear damage during 
early development (Figs. 2A, B, Table 2).  The mean operated (right) and non-operated 
(left) optical density ratio was 1.19 ± 0.08 (LSO) and 1.23 ± 0.03 (SPN). 
All nuclei of the SOC contained abundant PV-immunoreactive elements in the 
normal animals.  The highest density of PV-immunoreactive somata was found in the 
MNTB and the LSO.  Many PV immunoreactive somata were also located in the SPN 
and in the periolivary areas.  The neuropil in the whole SOC was very intensely PV 
immunoreactive.  As demonstrated by optical density determinations, 
PV-immunoreactive cells in the SOC contralateral to the ablated side were less intensely 
labeled.  The mean operated (right) and non-operated (left) optical density ratios were 
1.23 ± 0.11 (LSO) and 1.30 ± 0.07 (SPN), respectively (Figs. 2C, D, Table 2). 
-----Figure 2 and Table 2 Here----- 
 Cochlear ablation during early development is known to cause a reduction in 
the size of the cochlear nucleus ipsilateral to the lesion.  We used Image J in the 
present study and determined that as compared to each of the contralateral subdivisions 
of the CN, the volumes of the AVCN, PVCN and DCN were reduced by 55.7 ± 17.1%, 
62.1 ± 17.4% and 21.5 ± 10.2%, respectively, (mean ± SD).  Our results confirm 
previous reports on the CN volume reduction [10].   
 
Discussion 
Hearing loss produced by cochlear damage during early development can result 
in persistent changes in the organization of central auditory structures in adults.  
Although a number of previous studies have revealed changes in the morphology, 
projection and physiology of the central auditory pathway following cochlear ablation, 
the changes in neurotransmitter release have yet to be studied in detail [11].  CaBPs 
have been implicated in neurotransmitter release, and thus, immunostaining of these 
proteins might be used to follow the subtle changes that occur in neuronal activity.  
Since the presence of CaBPs is correlated with definite developmental stages of the 
central auditory system, CaBPs may also be the key to understanding neurotransmitter 
release in the mammalian auditory brainstem development.   
Our results indicated that there were corresponding changes in the expression 
of the CaBPs, CB and PV, in the contralateral SOC nuclei of the rats subjected to early 
unilateral cochlear ablation, which suggests there were changes in regulation of the 
neurotransmitters in these structures.  Cochlear ablation before the onset of hearing 
resulted in a decrease in the level of immunostaining of the CaBPs within the 
contralateral SOC, as compared to the ipsilateral side and staining seen for the control 
animals.  The decrease of CaBPs may suggest that there is a decrease in the calcium 
concentration that is related to the decreased activity [12].  Our results suggest that 
there is downregulation of the neuroactivity in the contralateral SOC.
 Another main finding in the present study was the occurrence of a substantial 
decrease in the number of CB and PV immunoreactive neurons, although there was no 
change noted in the total number of neurons in the MNTB following the unilateral 
cochlear ablation.  The SOC is the initial site for the convergence of binaural input and 
is most likely involved in the localization of sounds [13].  As such, the SOC plays an 
important role in the formation of sensitivity to interaural comparisons of intensity and 
time for stimuli that reach the two ears.  In the SOC, the MNTB supplies a major input 
to the ipsilateral LSO, relaying information from the contralateral CN.  The LSO and 
MNTB have been reported to work as a single functional unit [14].  The MNTB assists 
this functional unit by providing the LSO with input from the contralateral ear [15].  
Unilateral cochlear ablation reduces auditory inputs to the SOC and causes the outputs 
to be out of balance.  However, the cresyl violet staining on both sides did not indicate 
there was any observable decrease in the number of the MNTB neurons.  Additionally, 
between both sides in the control animals and for the lesioned side in ablated animals, 
there were no statistically significant differences noted for the number of CB and PV 
reactive cells in the MNTB.  This finding implies that the immunoreactivity of the 
CaBPs for the MNTB in the ablated side is not affected by unilateral cochlear ablation 
during early development.  It is possible that this could be because the MNTB on the 
ablated side is projected from the CN of the non-ablated side.  There is also the 
possibility that the monaural input is responsible for the differences in the 
immunostaining of the CaBPs that was noted between the ipsilateral and contralateral 
SOC in the present study.   
Matsubara et al. has suggested that CB is specific for “relay” neurons in a 
system that requires rapid, reliable transmission of impulses with minimal local 
processing or integration [7].  MNTB principal neurons most certainly receive secure 
synaptic input from the CN and these neurons have been reported to be intensely 
glycine-immunoreactive in the guinea pig [16]. There is strong evidence that glycine is 
a major inhibitory neurotransmitter in the mammalian central nervous system and 
additionally, the projection from the MNTB to the LSO is also considered to be 
inhibitory [17].  Our results suggest that the decrease in the immunoreactivity of the 
CaBPs is related to the inactivity of the inhibitory nervous system in the contralateral 
MNTB that occurs when there is unilateral cochlear ablation prior to the onset of 
hearing.  We also observed a substantial decrease in CB immunoreactivity in the 
contralateral SPN and LSO, as well as in the contralateral MNTB.  The PV 
immunostaining pattern that was observed following neonatal cochlear ablation in the 
SOC was similar to the CB immunostaining in this study.   
Cochlear ablation leads to the loss of CN neurons in cases where ablation is 
performed during early development in rats and gerbils [10].  We also observed a 
volume loss in the CN, in particular for the AVCN and PVCN.  There was a significant 
ipsilateral decrease in the volume of the VCNs, as compared with that seen for the DCN.  
This result suggests that the loss of neuronal connection from the CN to the 
contralateral MNTB causes a decrease in MNTB neuronal activity, even though it does 
not affect neuronal survival.  In rat, projection to the MNTB comes from the 
contralateral globular/bushy cells of the VCN [18].  Born and Rubel were the first to 
describe the age-dependent change in the susceptibility of the avian CN neurons to 
deafferentation.  Studies on mammals have indicated that the change in sensitivity to 
afferent deprivation in the mammalian VCN is temporally related to hearing onset [19].  
In gerbil CN, there is no loss of CN neurons observed following cochlear removal after 
P7, which is 5 days before the onset of hearing at P12.  Mean volume reduction of the 
deafferented CN did not differ significantly between P11 and P93 [20].  There is the 
possibility that the downregulation of the CaBPs in the SOC might be caused by the loss 
of CN neurons.  Further investigations using unilateral cochlear damage models 
without CN volume loss and cochlear ablation just before the onset of hearing will be 
required in order to clarify the real effect of the congenital hearing loss.  Not only 
deafness, cochlear ablation itself, destructive deaf model, may have made effect our 
result.  Congenital deaf model less damage of inner ear is more ideal for understanding 
human congenital deafness.  Furthermore, although we used a unilateral deaf model of 
adult stage (4 months) of rats, to be able to understand the central auditory system of 
congenitally deaf children, a bilateral deaf model at earlier times needs to be examined. 
 
Acknowledgements 
 This study was supported by a Grant-in-Aid for Scientific Research from the 
Ministry of Education, Culture, Sports, Science and Technology of Japan (#19591961) 
 
References 
1. Russell FA, Moore DR: Afferent reorganisation within the superior olivary 
complex of the gerbil: development and induction by neonatal, unilateral cochlear 
removal. J Comp Neurol 1995;352:607-625. 
2. Kitzes LM, Kageyama GH, Semple MN, Kil J: Development of ectopic 
projections from the ventral cochlear nucleus to the superior olivary complex induced 
by neonatal ablation of the contralateral cochlea. J Comp Neurol 1995;353:341-363. 
3. Ryugo DK, Rosenbaum BT, Kim PJ, Niparko JK, Saada AA: Single unit 
recordings in the auditory nerve of congenitally deaf white cats: morphological 
correlates in the cochlea and cochlear nucleus. J Comp Neurol 1998;397:532-548. 
4. Friauf E: Distribution of calcium-binding protein calbindin-D28k in the 
auditory system of adult and developing rats. J Comp Neurol 1994;349:193-211. 
5. Celio MR: Calbindin D-28k and parvalbumin in the rat nervous system. 
Neuroscience 1990;35:375-475. 
6. Andressen C, Blumcke I, Celio MR: Calcium-binding proteins: selective 
markers of nerve cells. Cell Tissue Res 1993;271:181-208. 
7. Matsubara JA: Calbindin D-28K immunoreactivity in the cat's superior olivary 
complex. Brain Res 1990;508:353-357. 
8. Lohmann C, Friauf E: Distribution of the calcium-binding proteins 
parvalbumin and calretinin in the auditory brainstem of adult and developing rats. J 
Comp Neurol 1996;367:90-109. 
9. Caillard O, Moreno H, Schwaller B, Llano I, Celio MR, Marty A: Role of the 
calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad 
Sci U S A 2000;97:13372-13377. 
10. Moore DR, Rogers NJ, O'Leary SJ: Loss of cochlear nucleus neurons following 
aminoglycoside antibiotics or cochlear removal. Ann Otol Rhinol Laryngol 
1998;107:337-343. 
11. Oleskevich S, Walmsley B: Synaptic transmission in the auditory brainstem of 
normal and congenitally deaf mice. J Physiol 2002;540:447-455. 
12. Celio MR, Heizmann CW: Calcium-binding protein parvalbumin as a neuronal 
marker. Nature 1981;293:300-302. 
13. Masterton B, Jane JA, Diamond IT: Role of brainstem auditory structures in 
sound localization. I. Trapezoid body, superior olive, and lateral lemniscus. J 
Neurophysiol 1967;30:341-359. 
14. Glendenning KK, Hutson KA, Nudo RJ, Masterton RB: Acoustic chiasm II: 
Anatomical basis of binaurality in lateral superior olive of cat. J Comp Neurol 
1985;232:261-285. 
15. Spangler KM, Warr WB, Henkel CK: The projections of principal cells of the 
medial nucleus of the trapezoid body in the cat. J Comp Neurol 1985;238:249-262. 
16. Wenthold RJ, Huie D, Altschuler RA, Reeks KA: Glycine immunoreactivity 
localized in the cochlear nucleus and superior olivary complex. Neuroscience 
1987;22:897-912. 
17. Moore MJ, Caspary DM: Strychnine blocks binaural inhibition in lateral 
superior olivary neurons. J Neurosci 1983;3:237-242. 
18. Friauf E, Ostwald J: Divergent projections of physiologically characterized rat 
ventral cochlear nucleus neurons as shown by intra-axonal injection of horseradish 
peroxidase. Exp Brain Res 1988;73:263-284. 
19. Born DE, Rubel EW: Afferent influences on brain stem auditory nuclei of the 
chicken: neuron number and size following cochlea removal. J Comp Neurol 
1985;231:435-445. 
20. Tierney TS, Russell FA, Moore DR: Susceptibility of developing cochlear 
nucleus neurons to deafferentation-induced death abruptly ends just before the onset of 
hearing. J Comp Neurol 1997;378:295-306. 
 
Figure legends 
Table 1; Numbers of neurons in the MNTB in control and ablated animals. 
Table 2; Optical density values for CB and PV in the LSO and SPN after unilateral early 
cochlear ablation. 
Figure 1; High magnification images illustrating the pattern of the cresyl violet stain (A, 
B), CB immunoreactivity (C, D) and PV immunoreactivity (E, F) in coronal sections of 
the MNTB in ablated rats.  Scale bar = 100 μm in B (applies to A - F) 
Figure 2; Low magnification images illustrating the pattern of the CB immunoreactivity 
(A, B) and PV immunoreactivity (C, D) in coronal sections of the LSO and the SPN in 
ablated rats.  Scale bar = 200 μm in B (applies to A - D) 
 
Table 1 Numbers of cells in MNTB in control and ablated animals 
 
 Left side (Contralateral) Right side (Ipsilateral)   
 Cresyl violet CB  PV Cresyl violet CB PV n
Control  1190.3 ± 100.9 343 ± 125.7 210 ± 35.4 1207.3 ± 231.5 348 ± 122.4 201.3 ± 41.2 3
Right ablated  1133.4 ± 208.5 162.4 ± 70.4 * 151 ± 96.3 1199.1 ± 114.9 327.9 ± 84.4 254.1 ± 114.2 7
 
Values expressed are means and standard deviations. Asterisk(*) indicates significant differences between sides in 
ablated animals. 
Table 2 Optical Density Values for CB and PV in LSO and SPN after unilateral cochlear ablation. 
 
  Left side (Contralateral) Right side (Ipsilateral)  Left / Right ratio  
CB      
LSO  219.5 ± 5.4 * 184.7± 10.1   1.19 ± 0.08 
SPN  213.5 ± 6.0 * 173.9 ± 8.1  1.23 ± 0.03 
PV      
LSO  138.5 ± 6.7 * 112.7 ± 6.3  1.23 ± 0.11 
SPN  169.0 ± 7.9 * 129.9 ± 11.1  1.30 ± 0.07 
 
Values expressed are means and standard deviations. 
Asterisk(*) indicates significant differences between sides; LSO, lateral superior olivary nucleus; SPN, superior 
paraolivary nucleus. 
 


